Literature DB >> 17345094

Endothelial dysfunction in adult patients with a history of Kawasaki disease.

Ayumi Niboshi1, Kenji Hamaoka, Koichi Sakata, Nozomi Yamaguchi.   

Abstract

To assess the existence of endothelial dysfunction and the possibility of the early onset of atherosclerosis in the chronic stage of Kawasaki disease (KD), we examined endothelial function in adult patients late after the onset of KD. We evaluated two age-matched groups: 35 adult KD patients (KD group) (mean age, 27.0 years; mean interval time, 24.1 years), and 36 healthy adults (control group). To assess vascular endothelial function, flow-mediated dilatation (%FMD) of the brachial artery and urinary nitrites and nitrates (NOx) were examined. We also measured adhesion molecules and several coagulation-fibrinolysis markers. In addition, we measured high-sensitive C-reactive protein (hs-CRP) as a chronic inflammatory marker, and brachial-ankle pulse wave velocity (baPWV) as a marker for arterial stiffness. %FMD was significantly reduced in the KD group when compared with that of the control group (KD group, 10.4 +/- 2.6%; control group, 14.4 +/- 3.2%, p<0.05), particularly in patients with coronary artery lesions. Thrombin-antithrombin III complex values were higher in the KD group, although no significant differences were observed in the other markers for endothelial function. Hs-CRP was significantly elevated only in the patients with coronary aneurysms. Furthermore, in the male KD patients, the baPWV values were significantly higher than those in the control subjects. This study revealed that the adult patients with a history of KD had systemic vascular endothelial dysfunction, and also suggested that a history of KD was possibly one of the risk factors for early onset of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17345094     DOI: 10.1007/s00431-007-0452-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors.

Authors:  Christian K Roberts; Andrew K Chen; R James Barnard
Journal:  Atherosclerosis       Date:  2006-10-19       Impact factor: 5.162

3.  Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.

Authors:  G O'Driscoll; D Green; R R Taylor
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

4.  Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease.

Authors:  T Kadono; H Sugiyama; M Hoshiai; M Osada; T Tan; A Naitoh; M Watanabe; K Koizumi; S Nakazawa
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 5.  Novel clinical markers of vascular wall inflammation.

Authors:  G J Blake; P M Ridker
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

6.  Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study.

Authors:  A Suzuki; S Miyagawa-Tomita; K Komatsu; T Nishikawa; Y Sakomura; T Horie; M Nakazawa
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

7.  Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis.

Authors:  K Takahashi; T Oharaseki; S Naoe
Journal:  Pediatr Cardiol       Date:  2001 Mar-Apr       Impact factor: 1.655

8.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

9.  Nitrite and nitrate measurements in human urine by capillary electrophoresis.

Authors:  Edward Morcos; N Peter Wiklund
Journal:  Methods Mol Biol       Date:  2004

10.  Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases.

Authors:  H Kato; E Ichinose; T Kawasaki
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

View more
  26 in total

Review 1.  Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease.

Authors:  Han Zhang; Ming-Guo Xu; Li-Jian Xie; Min Huang; Jie Shen; Ting-Ting Xiao
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

2.  Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.

Authors:  Chao Duan; Zhong-Dong Du; Yu Wang; Li-Qun Jia
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

3.  Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.

Authors:  Cedric Manlhiot; Leonardo R Brandão; Zeeshanefatema Somji; Amy L Chesney; Catherine MacDonald; Rebecca C Gurofsky; Tarun Sabharwal; Nita Chahal; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2010-04-30       Impact factor: 1.655

4.  Acute myocardial infarction caused by transient coronary vasospasm in a child with Kawasaki disease and no coronary aneurysms.

Authors:  Subhashini Subramanian; Winston E Gaum
Journal:  Pediatr Cardiol       Date:  2010-04-27       Impact factor: 1.655

5.  The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Authors:  S Blankier; B W McCrindle; S Ito; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

6.  Orthostatic and Exercise Effects in Children Years After Kawasaki Disease.

Authors:  Yoshihiro Nakamura; Takehiro Hama; Yoshie Nakamura; Hideki Tsukada; Yoichiro Oda; Shoichi Awa
Journal:  Pediatr Cardiol       Date:  2019-10-08       Impact factor: 1.655

7.  Carotid intima-media thickness in children with Kawasaki disease.

Authors:  Raghvendra Singh Meena; Manojkumar Rohit; Anju Gupta; Surjit Singh
Journal:  Rheumatol Int       Date:  2013-08-08       Impact factor: 2.631

8.  Prevalence of Coronary Artery Disease Risk Factors and Metabolic Syndrome in Children with Heart Disease.

Authors:  Adam L Ware; Paul C Young; Cindy Weng; Angela P Presson; L LuAnn Minich; Shaji C Menon
Journal:  Pediatr Cardiol       Date:  2017-10-23       Impact factor: 1.655

9.  A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease.

Authors:  David Burgner; Sonia Davila; Willemijn B Breunis; Sarah B Ng; Yi Li; Carine Bonnard; Ling Ling; Victoria J Wright; Anbupalam Thalamuthu; Miranda Odam; Chisato Shimizu; Jane C Burns; Michael Levin; Taco W Kuijpers; Martin L Hibberd
Journal:  PLoS Genet       Date:  2009-01-09       Impact factor: 5.917

10.  Carotid intima-media thickness and pulse wave velocity after recovery from kawasaki disease.

Authors:  Soo Jin Lee; Hye Mi Ahn; Jung Hyun You; Young Mi Hong
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.